Clinical Trial 40207

share

Garden Grove, CA 92845


Study Summary:

A Phase 2, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate
Efficacy, Safety, Tolerability, and Pharmacokinetics of 3 Dose levels of TAK-831 in Adjunctive
Treatment of Adult Subjects With Negative Symptoms of Schizophrenia


Qualified Participants Must:

• 1. The subject is male or female and aged 18 to 50 years
• 2. The subject has a current diagnosis of schizophrenia


Qualified Participants May Receive:

Compensation for time and travel 


Study is Available At:

CNS Network
12772 Valley View Ave, Suite 3
Garden Grove, CA 92845
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.